Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter studyResearch in context by Li Bao, Yu-Tong Wang, Peng Liu, Min-Qiu Lu, Jun-Ling Zhuang, Mei Zhang, Zhong-Jun Xia, Zhen-Ling Li, Ying Yang, Zhen-Yu Yan, Hong-Mei Jing, Fei Dong, Wen-Ming Chen, Yin Wu, He-Bing Zhou, Rong Fu, Yu-Ping Gong, Wen-Rong Huang, Yong-Qing Zhang

Get full text

Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age by Peng Zhao, Ming Hou, Yi Liu, Hui-Xin Liu, Rui-Bin Huang, Hong-Xia Yao, Ting Niu, Jun Peng, Ming Jiang, Yan-Qiu Han, Jian-Da Hu, Hu Zhou, Ze-Ping Zhou, Lin Qiu, Lian-Sheng Zhang, Xin Wang, Hua-Quan Wang, Ru Feng, Lin-Hua Yang, Liang-Ming Ma, Shun-Qing Wang, Pei-Yan Kong, Wen-Sheng Wang, Hui-Ping Sun, Jing Sun, He-Bing Zhou, Tie-Nan Zhu, Li-Ru Wang, Jing-Yu Zhang, Qiu-Sha Huang, Xiao Liu, Hai-Xia Fu, Yue-Ying Li, Qian-Fei Wang, Qian Jiang, Hao Jiang, Jin Lu, Xiao-Hui Zhang

Get full text